Loring Wolcott & Coolidge Fiduciary Advisors’s Dentsply Sirona XRAY Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-26,980	Closed	-$355K	–	560
2025 Q3	$355K	Buy	+26,980	New	+$391K	﹤0.01%	272
2024 Q3	–	Sell	-325	Closed	-$8.71K	–	599
2024 Q2	$8.71K	Hold	325	–	–	﹤0.01%	497
2024 Q1	$9.87K	Hold	325	–	–	﹤0.01%	496
2023 Q4	$11.3K	Hold	325	–	–	﹤0.01%	492
2023 Q3	$9.28K	Sell	325 -100	-24%	-$3.8K	﹤0.01%	522
2023 Q2	$17K	Buy	425 +100	+31%	+$3.98K	﹤0.01%	514
2023 Q1	$12.8K	Hold	325	–	–	﹤0.01%	502
2022 Q4	$10.3K	Hold	325	–	–	﹤0.01%	501
2022 Q3	$9K	Hold	325	–	–	﹤0.01%	531
2022 Q2	$12K	Hold	325	–	–	﹤0.01%	536
2022 Q1	$16K	Hold	325	–	–	﹤0.01%	528
2021 Q4	$18K	Sell	325 -1,000	-75%	-$55K	﹤0.01%	546
2021 Q3	$77K	Sell	1,325 -44	-3%	-$2.71K	﹤0.01%	418
2021 Q2	$87K	Buy	+1,369	New	+$90.2K	﹤0.01%	415
2021 Q1	–	Sell	-3,393	Closed	-$178K	–	724
2020 Q4	$178K	Buy	3,393 +48	+1%	+$2.37K	﹤0.01%	288
2020 Q3	$146K	Buy	3,345 +1,000	+43%	+$44.2K	﹤0.01%	285
2020 Q2	$103K	Hold	2,345	–	–	﹤0.01%	302
2020 Q1	$91K	Hold	2,345	–	–	﹤0.01%	304
2019 Q4	$133K	Hold	2,345	–	–	﹤0.01%	312
2019 Q3	$125K	Sell	2,345 -56	-2%	-$3.01K	﹤0.01%	309
2019 Q2	$140K	Hold	2,401	–	–	﹤0.01%	297
2019 Q1	$119K	Buy	2,401 +56	+2%	+$2.47K	﹤0.01%	307
2018 Q4	$87K	Sell	2,345 -200	-8%	-$7.28K	﹤0.01%	336
2018 Q3	$96K	Sell	2,545 -400	-14%	-$16.7K	﹤0.01%	355
2018 Q2	$129K	Sell	2,945 -1,281	-30%	-$60.2K	﹤0.01%	325
2018 Q1	$213K	Hold	4,226	–	–	﹤0.01%	271
2017 Q4	$278K	Sell	4,226 -41	-1%	-$2.61K	0.01%	247
2017 Q3	$255K	Buy	4,267 +41	+1%	+$2.44K	﹤0.01%	252
2017 Q2	$262K	Sell	4,226 -27	-0.6%	-$1.71K	0.01%	248
2017 Q1	$266K	Hold	4,253	–	–	0.01%	245
2016 Q4	$246K	Hold	4,253	–	–	0.01%	246
2016 Q3	$253K	Buy	+4,253	New	+$261K	0.01%	242
2016 Q1	–	Sell	-4,165	Closed	-$253K	–	655
2015 Q4	$253K	Hold	4,165	–	–	0.01%	248
2015 Q3	$215K	Hold	4,165	–	–	0.01%	263
2015 Q2	$215K	Sell	4,165 -1,600	-28%	-$82.8K	0.01%	263
2015 Q1	$293K	Sell	5,765 -1,000	-15%	-$51.6K	0.01%	254
2014 Q4	$360K	Sell	6,765 -6,920	-51%	-$352K	0.01%	229
2014 Q3	$624K	Sell	13,685 -420	-3%	-$19.8K	0.02%	168
2014 Q2	$668K	Sell	14,105 -16,325	-54%	-$759K	0.02%	170
2014 Q1	$1.4M	Sell	30,430 -2,650	-8%	-$123K	0.04%	127
2013 Q4	$1.6M	Sell	33,080 -2,875	-8%	-$135K	0.04%	121
2013 Q3	$1.56M	Sell	35,955 -2,460	-6%	-$105K	0.05%	120
2013 Q2	$1.57M	Buy	+38,415	New	+$1.6M	0.05%	127

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's XRAY Position: Q4 2025 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Dentsply Sirona (XRAY) in Q4 2025, closing a stake of 26,980 shares — an estimated $355K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in XRAY in Q2 2013 and held it in 43 quarters. The position peaked at $1.6M in Q4 2013. 361 funds tracked by Wall St. Rank hold XRAY as of Q4 2025.

Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Dentsply Sirona position as of Q4 2025 after selling out during the quarter.
Loring Wolcott & Coolidge Fiduciary Advisors sold 26,980 Dentsply Sirona shares in Q4 2025, an estimated $355K.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Dentsply Sirona in Q2 2013 and held it in 43 quarters.
Loring Wolcott & Coolidge Fiduciary Advisors's Dentsply Sirona position peaked at $1.6M in Q4 2013.
361 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2025.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2025, filed 28 Jan 2026.